Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Inflammatory Response
T Cell Types and Functions
TGF - β Signaling Pathway
NF-κB-dependent Signaling Pathway
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Dec 28, 2025

Screening Assays to Characterize Novel Endothelial Regulators Involved in the Inflammatory Response
Published on: September 15, 2017
Savvas N Savvides1,2, Dirk Elewaut3,4
1VIB-UGent Center for Inflammation Research, Ghent, Belgium. savvas.savvides@ugent.be.
No abstract available in PubMed .